Stocks
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.41 | -0.27 | -0.62 | -1.90 | -2.46 | -2.07 | |||
| Changes by years, y/y, % | -38% | -35% | +131% | +208% | +30% | +30.2% | |||
Edwards Lifesciences. Debt/EBITDA
Edwards Lifesciences. Debt/EBITDA, changes, %
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | -1.77 | -1.88 | -1.80 | -2.53 | -2.07 | -2.07 | ||
| Changes by years, y/y, % | +174% | +142% | -20% | +35% | +17% | |||
| Changes by quarters, q/q, % | -6% | +7% | -4% | +40% | -18% | |||
